| Literature DB >> 35889617 |
Rajakumar Govindasamy1, Mydhili Govindarasu2, Salman S Alharthi3, Preeyanghaa Mani4, Neppolian Bernaurdshaw4, Thandapani Gomathi5, Mohammad Azam Ansari6, Mohammad N Alomary7, Banan Atwah8, M Shaheer Malik9, V Devi Rajeswari10, Kaliaperumal Rekha11, Saleh A Ahmed9,12, Muthu Thiruvengadam13,14.
Abstract
Due to their appropriate physicochemical properties, nanoparticles are used in nanomedicine to develop drug delivery systems for anticancer therapy. In biomedical applications, metal oxide nanoparticles are used as powerful and flexible multipurpose agents. This work described a green synthesis of Y2O3 nanoparticles (NPs) using the sol-gel technique with the use of aqueous leaf extracts of Lantana camara L (LC). These nanoparticles were characterized with the aid of different methods, including UV, X-ray diffraction (XRD), Fourier transformed infrared spectroscopy (FTIR), transmitted electron microscopy (TEM), and photocatalytic degradation. Y2O3 nanoparticles showed excellent antibacterial activity against Gram-positive Bacillus subtilis and Gram-negative Escherichia coli with a 10 to 15 mm inhibitory zone. Green Y2O3 NPs were released with a 4 h lag time and 80% sustained release rate, indicating that they could be used in drug delivery. In addition, the bioavailability of green Y2O3 NPs was investigated using cell viability in cervical cancer cell lines. These green-synthesized Y2O3 NPs demonstrated photocatalytic degradation, antibacterial, and anticancer properties.Entities:
Keywords: HeLa cells; Lantana camara; Y2O3 nanoparticles; cervical cancer; photocatalytic degradation
Year: 2022 PMID: 35889617 PMCID: PMC9320374 DOI: 10.3390/nano12142393
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.719
Figure 1UV-vis absorption spectra of (a) green synthesized LC Y2O3 NPs suspended in ethanol and (b) the color changes following the synthesis of LC Y2O3 NPs.
Figure 2FTIR spectrum of the L. camara leaf extract and green-synthesized LC Y2O3 NPs.
Figure 3XRD pattern of green synthesized LC Y2O3 NPs (JCPDS card no. 83-0927).
Figure 4(a) TEM image of the green synthesized LC Y2O3 NPs. (b) Photocatalytic degradation of Rhodamine B utilizing the green synthesized LC Y2O3 NPs.
Figure 5The green synthesized LC Y2O3 NPs showed an improved zone of inhibition against (a) Bacillus, and (b) E. coli, compared to Y2O3 NPs.
Figure 6Green LC Y2O3 NPs inhibit the cell viability of human cervical carcinoma HeLa cells. HeLa cells were treated for 24 h with various concentrations of LC extract and green LC Y2O3 NPs.
Figure 7In vitro release of optimized LC Y2O3 NPs. The drug shows rapid NPs release and aqueous drug solution. Around 85% of the drug was released in the first 30 min of the study. A saturation status was then observed in the drug release. On the other hand, optimized LC Y2O3 NPs showed a more controlled drug release pattern than LC leaf extract and Y2O3 NPs.